Login to Your Account

Genexine cleared to initiate second clinical trial of GX-188E

By Haky Moon
Staff Writer

Tuesday, June 20, 2017

HONG KONG – The collaboration between Merck & Co. Inc. and South Korean company Genexine Inc. is just a few steps away from tackling HPV-associated cancers.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription